Pulmonary arterial hypertension (PAH) is a disease that progress over time and is defined
as an increase in pulmonary arterial pressure and pulmonary vascular resistance that …

The typical cause of death in pulmonary hypertension (PH) is right ventricular (RV) failure,
with females showing better survival rates than males. Recently, metabolic shift and …

Background Aberrant expression of microRNAs (miRNAs) has been associated with the
pathogenesis of pulmonary hypertension (PH). It is, however, not clear whether miRNAs are …

Pulmonary arterial hypertension (PAH) is a progressive disease characterised by increased
pulmonary vascular resistance and pulmonary artery remodelling as result of increased …

Objective—Hypoxic pulmonary hypertension (HPH) is characterized by proliferative vascular
remodeling. Abnormal pulmonary artery smooth muscle cells proliferation and endothelial …

Pulmonary arterial hypertension (PAH) is a complex and devastating disease with a poor
long-term prognosis. While women are at increased risk for developing PAH, they exhibit …

How two-chambered hearts in basal vertebrates have evolved from single-chamber hearts
found in ancestral chordates remains unclear. Here, we show that the teleost sinus venosus …

Although women are more susceptible to pulmonary arterial hypertension (PAH) than men,
their right ventricular (RV) function is better preserved. Estrogen receptor-α (ERα) has been …

Anesthesiologists involved in the management of pregnant patients with pulmonary
hypertension must have detailed knowledge of pathophysiological alterations in pregnancy …

Pulmonary arterial hypertension (PAH), a form of pulmonary hypertension, is a complex
disease of multifactorial origin. While new developments regarding pathophysiological …